P. Byron

发表

Inhaling medicines: delivering drugs to the body through the lungs

Peter R. Byron, J. Patton, John S. Patton, 2007, Nature Reviews Drug Discovery.

Validation of an improved Wood's rotating disk dissolution apparatus.

R N Jashnani, P R Byron, R N Dalby, 1993, Journal of pharmaceutical sciences.

Effects of heat treatment on the permeability of polyvinyl alcohol films to a hydrophilic solute.

P. Byron, R. Dalby, Peter R. Byron, 1987, Journal of pharmaceutical sciences.

The Effects of Formulation Additives on the Degradation of Freeze-Dried Ribonuclease A

P. Byron, P. Deluca, M. W. Townsend, 1990, Pharmaceutical Research.

Tobramycin Disposition in the Rat Lung Following Airway Administration

P. Byron, Min Li, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Drug delivery via the respiratory tract.

J. Patton, P. Byron, Peter R. Byron, 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.

D. McRobbie, W. Finlay, C. Lange, 2010, Journal of aerosol medicine and pulmonary drug delivery.

Respirable Microspheres for Inhalation

M. Sakagami, P. Byron, 2005, Clinical pharmacokinetics.

Airway Retention and Pulmonary Absorption of Poly-α,β-[N(2-hydroxyethyl)-D, L-aspartamide]

F. Rypáček, P. Byron, Zhuang Sun, 1991 .

Solute Absorption from the Airways of the Isolated Rat Lung. V. Charge Effects on the Absorption of Copolymers of N(2-hydroxyethyl)-DL-Aspartamide with DL-Aspartic Acid or Dimethylaminopropyl-DL-Aspartamide

F. Rypáček, P. Byron, John Z. Sun, 1999, Pharmaceutical Research.

Solute Absorption from the Airways of the Isolated Rat Lung. IV. Mechanisms of Absorption of Fluorophore-Labeled Poly-α,β-[N(2-Hydroxyethyl)-DL-Aspartamide]

Zhuang Sun, F. Rypáček, P. Byron, 1994, Pharmaceutical Research.

Physicochemical effects on lung disposition of pharmaceutical aerosols

P. Byron, 1993 .

Effect of energy on propylene glycol aerosols using the capillary aerosol generator.

M. Hindle, P. Byron, X. Shen, 2004, International journal of pharmaceutics.

Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.

Xihao Li, M. Hindle, P. Byron, 2005, International journal of pharmaceutics.

Control of particle size by coagulation of novel condensation aerosols in reservoir chambers.

M. Hindle, P. Byron, J. Hong, 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Optimized Inhalation Aerosols. II. Inertial Testing Methods for Particle Size Analysis of Pressurized Inhalers

A. Hickey, P. Byron, E. Phillips, 1990, Pharmaceutical Research.

Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane

P. Byron, E. Phillips, 1994 .

Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.

M. Sakagami, P. Byron, Akihiko Kamiya, 2009, Journal of pharmaceutical sciences.

Dry powder aerosol generation in different environments: Performance comparisons of albuterol, albuterol sulfate, albuterol adipate and albuterol stearate

P. Byron, R. Jashnani, 1996 .

Calculations of optimum pharmacokinetic drug supply rates for maximum duration during multiple dose therapy by prodrug administration

R. Notari, P. Byron, Huang Mei-ying, 1978 .

Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation.

P. Byron, 1986, Journal of pharmaceutical sciences.

Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler.

A. Lichtman, B. Martin, P. Byron, 2002, Drug and alcohol dependence.

Pharmacological evaluation of aerosolized cannabinoids in mice.

A. Lichtman, R. Razdan, B. Martin, 2000, European journal of pharmacology.

Inhaled Iloprost Improves Right Ventricular Function In The Sugen5416/Hypoxia Model Of Severe Pulmonary Hypertension

L. Farkas, N. Voelkel, M. Sakagami, 2012, ATS 2012.

Iloprost reverses established fibrosis in experimental right ventricular failure

L. Farkas, N. Voelkel, B. V. Van Tassell, 2015, European Respiratory Journal.

Peptidoleukotriene (PLT) Release and Absorption from the Airways of the Isolated Perfused Guinea Pig Lung Following Chemical and Antigenic Challenge

J. Venitz, P. Byron, R. Kovelesky, 1999, Pharmaceutical Research.

Immune potential in human uraemia. 1. Relationship of glomerular filtration rate to depression of immune potential.

P. Byron, N. Mallick, G. Taylor, 1976, Journal of clinical pathology.

In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing.

Renishkumar R Delvadia, J. Venitz, P. Longest, 2016, Journal of aerosol medicine and pulmonary drug delivery.

Drug delivery devices: issues in drug development.

P. Byron, 2004, Proceedings of the American Thoracic Society.

In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition.

Renishkumar R Delvadia, M. Hindle, P. Longest, 2013, Journal of aerosol medicine and pulmonary drug delivery.

In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth-Throat Models and In Vitro-In Vivo Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler.

Renishkumar R Delvadia, M. Hindle, P. Byron, 2018, Journal of aerosol medicine and pulmonary drug delivery.

Some Future Perspectives for Unit Dose Inhalation Aerosols

P. Byron, 1986 .

Drug-surfactant-propellant interactions in HFA-formulations.

C. Vervaet, P. Byron, Peter R. Byron, 1999, International journal of pharmaceutics.

Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs.

J. Venitz, P. Lilly, P. Byron, 2011, Toxicology.

Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols.

P. Byron, J. Peart, Reshma Kotian, 2009, Journal of aerosol medicine and pulmonary drug delivery.

In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults.

Renishkumar R Delvadia, M. Hindle, P. Longest, 2013, Journal of aerosol medicine and pulmonary drug delivery.

Adhesion of Powders for Inhalation: An Evaluation of Drug Detachment from Surfaces Following Deposition from Aerosol Streams

M. J. Clarke, P. Byron, J. Peart, 2002, Pharmaceutical Research.

Dose emissions from marketed dry powder inhalers

Peter R. Byron, Michael Hindle, M. Hindle, 1995 .

Drug Delivery Devices

P. Byron, 2012 .

Spinning-disk generation and drying of monodisperse solid aerosols with output concentrations sufficient for single-breath inhalation studies.

A. Hickey, P. Byron, 1987, Journal of pharmaceutical sciences.

Respiratory Drug Delivery

P. Byron, 1989 .

Aerosol Electrostatics I: Properties of Fine Powders Before and After Aerosolization by Dry Powder Inhalers

John N. Staniforth, Peter R. Byron, Joanne Peart, 2004, Pharmaceutical Research.

Drug absorption from inhalation aerosols administered by positive-pressure ventilation. I: Administration of a characterized, solid disodium fluorescein aerosol under a controlled respiratory regime to the beagle dog.

A. Clark, P. Byron, 1985, Journal of pharmaceutical sciences.

Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy.

P. Byron, N. Mallick, G. Taylor, 1976, Journal of clinical pathology.

Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung

Peter R. Byron, P. Byron, 1990 .

Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.

Elaine M. Phillips, E. M. Phillips, P R Byron, 1998, Drug development and industrial pharmacy.

Pharmaceutical implications of particle growth at high relative humidities

Peter R. Byron, S. S. Davis, S. Davis, 1977 .

Perspectives on the Biopharmacy of Inhalation Aerosols

I. Gonda, P. Byron, 1978 .

Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.

R. Notari, P. Byron, 1976, Journal of pharmaceutical sciences.

Solute Absorption from the Airways of the Isolated Rat Lung. II. Effect of Surfactants on Absorption of Fluorescein

R. Niven, P. Byron, 2004, Pharmaceutical Research.

Preparation, characterization, and dissolution kinetics of two novel albuterol salts.

R N Jashnani, P R Byron, R N Dalby, 1993, Journal of pharmaceutical sciences.

Testing of dry powder aerosol formulations in different environmental conditions

P. Byron, R. Jashnani, R. Dalby, 1995 .

Airway-to-biophase transfer of inhaled oligonucleotides

S. Wu‐Pong, P. Byron, 1996 .

Insulin Self-association: Effects on Lung Disposition Kinetics in the Airways of the Isolated Perfused Rat Lung (IPRL)

M. Sakagami, P. Byron, Yinuo Pang, 2007, Pharmaceutical Research.

Numerical Simulations of Capillary Aerosol Generation: CFD Model Development and Comparisons with Experimental Data

M. Hindle, P. Longest, P. Byron, 2007 .

High-pressure liquid chromatographic assay for the determination of thyrotropin-releasing hormone and its common metabolites in a physiological salt solution circulated through the isolated perfused rat lung.

P. Byron, J. Visich, 1996, Journal of pharmaceutical and biomedical analysis.

A stability-indicating HPLC assay method for budesonide.

M. Hindle, P. Byron, S. Hou, 2001, Journal of pharmaceutical and biomedical analysis.

An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption.

A. Clark, P R Byron, P. Byron, 1986, Journal of pharmaceutical sciences.

The quantitative determination of aspirin and its degradation products in a model solution aerosol.

P R Byron, F E Blondino, P. Byron, 1995, Journal of pharmaceutical and biomedical analysis.

Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants

P. Byron, Timothy G. Carroll, H. Rozycki, 2003, Pediatric pulmonology.

Simultaneous partitioning and hydrolysis kinetics of amoxicillin and ampicillin.

E. Tomlinson, R. Notari, P. Byron, 1980, Journal of Pharmacy and Science.

Calculation of partition coefficient of an unstable compound using kinetic methods

E. Tomlinson, R. Notari, P. Byron, 1980 .

Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors.

M. Sakagami, F. Rypáček, P. Byron, 2002, Journal of pharmaceutical sciences.

Prediction of interfacial transfer kinetics. II. Solute ionization and aqueous phase ionic strength effects in two-phase transfer and rotating diffusion cells

M. Rathbone, P. Byron, 1986 .

Investigation of a Novel Condensation Aerosol Generator: Solute and Solvent Effects

Douglas D. Mcrae, Kenneth A. Cox, Peter R. Byron, 2003 .

Dosing Reproducibility from Experimental Albuterol Suspension Metered-Dose Inhalers

P. Byron, 1994, Pharmaceutical Research.

Axial Ratio Measurements for Early Detection of Crystal Growth in Suspension-Type Metered Dose Inhalers

P. Byron, R. Dalby, E. Phillips, 1993, Pharmaceutical Research.

Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants.

P R Byron, F E Blondino, P. Byron, 1998, Drug development and industrial pharmacy.

Drug absorption from inhalation aerosols administered by positive-pressure ventilation. II: Effect of disodium fluorescein aerosol particle size on fluorescein absorption kinetics in the beagle dog respiratory tract.

A. Clark, P. Byron, 1985, Journal of pharmaceutical sciences.

FLUORESCEIN PHARMACOKINETICS IN THE BEAGLE

P. Byron, C. V. Groom, A. Ruth Clark, 1981 .

Effect of a non-hygroscopic surfactant coating upon fluorescein absorption from the respiratory tract.

A. Hickey, P. Byron, 1987, Drug design and delivery.

The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition.

M. Sakagami, Masahiro Sakagami, P. Byron, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Solute Absorption from the Airways of the Isolated Rat Lung. III. Absorption of Several Peptidase-Resistant, Synthetic Polypeptides: Poly-(2-Hydroxyethyl)-Aspartamides

R. Niven, F. Rypáček, P. Byron, 1990, Pharmaceutical Research.

In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans.

P Worth Longest, Renishkumar R Delvadia, P. Longest, 2012, Journal of aerosol medicine and pulmonary drug delivery.

In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea.

Renishkumar R Delvadia, M. Hindle, P. Byron, 2017, Journal of aerosol medicine and pulmonary drug delivery.

Effects of surfactants on aerosol powders in suspension. Implications for airborne particle size

A. Hickey, P. Byron, R. Dalby, 1988 .

Preparation, characterization, and controlled release from coprecipitates of fluorescein and magnesium hydroxide.

A. Hickey, P. Byron, 1986, Journal of pharmaceutical sciences.

United States Pharmacopeia recommendations for the testing of inhalers.

P. Byron, 1998, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

Optimized Inhalation Aerosols. I. The Effects of Spherical Baffle Size and Position upon the Output of Several Pressurized Nonaqueous Suspension Formulations

A. Hickey, P. Byron, R. Dalby, 1989, Pharmaceutical Research.

Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions

Peter R. Byron, Richard N. Dalby, P. Byron, 2004, Pharmaceutical Research.

Aerosol drug delivery to intubated neonates.

P. Byron, H. Rozycki, G. Gutcher, 1992, Archives of disease in childhood.

Polystyrene microsphere spray standards based on CFC-free inhaler technology.

C. Vervaet, P. Byron, 2000, Journal of Aerosol Medicine.

Size distribution control of raw materials for dry-powder inhalers using the aerosizer with the aero-disperser

M. Hindle, M. Hindle, P. Byron, 1995 .

RANDOMIZED CONTROLLED TRIAL OF BECLOMETHASONE BY MDI vs SYSTEMIC DEXAMETHASONE IN INFANTS AT HIGH RISK FOR BPD. 1433

P. Byron, Timothy G. Carroll, H. Rozycki, 1996, Pediatric Research.